Patents by Inventor David Stamler

David Stamler has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods for the treatment of abnormal involuntary movement disorders
    Patent number: 11648244
    Abstract: Disclosed herein are new dosage regimens for deuterium-substituted benzoquinoline compounds, and methods for the treatment of abnormal muscular activity, movement disorders, and related conditions.
    Type: Grant
    Filed: August 2, 2017
    Date of Patent: May 16, 2023
    Assignee: Auspex Pharmaceuticals, Inc.
    Inventors: David Stamler, Michael Fangching Huang
  • BENZOQUINOLINE INHIBITORS OF VESICULAR MONOAMINE TRANSPORTER 2
    Publication number: 20230122780
    Abstract: The present invention relates to new benzoquinoline inhibitors of vesicular monoamine transporter 2 (VMAT2), pharmaceutical compositions thereof, and methods of use thereof.
    Type: Application
    Filed: April 14, 2022
    Publication date: April 20, 2023
    Inventor: David Stamler
  • Methods for the treatment of abnormal involuntary movement disorders
    Patent number: 11564917
    Abstract: Disclosed herein are new dosage regimens for deuterium-substituted benzoquinoline compounds, and methods for the treatment of abnormal muscular activity, movement disorders, and related conditions.
    Type: Grant
    Filed: October 2, 2017
    Date of Patent: January 31, 2023
    Assignee: Auspex Pharmaceuticals, Inc.
    Inventors: David Stamler, Michael Fangching Huang
  • Methods for the treatment of abnormal involuntary movement disorders
    Patent number: 11446291
    Abstract: Disclosed herein are new dosage regimens for deuterium-substituted benzoquinoline compounds, and methods for the treatment of abnormal muscular activity, movement disorders, and related conditions.
    Type: Grant
    Filed: March 25, 2021
    Date of Patent: September 20, 2022
    Assignee: Auspex Pharmaceuticals, Inc.
    Inventors: David Stamler, Michael Fangching Huang
  • Methods for the treatment of abnormal involuntary movement disorders
    Patent number: 11357772
    Abstract: Disclosed herein are new dosage regimens for deuterium-substituted benzoquinoline compounds, and methods for the treatment of abnormal muscular activity, movement disorders, and related conditions.
    Type: Grant
    Filed: January 21, 2021
    Date of Patent: June 14, 2022
    Assignee: AUSPEX PHARMACEUTICALS, INC.
    Inventors: David Stamler, Michael Huang
  • METHODS FOR THE TREATMENT OF ABNORMAL INVOLUNTARY MOVEMENT DISORDERS
    Publication number: 20210379051
    Abstract: Disclosed herein are new dosage regimens for deuterium-substituted benzoquinoline compounds, and methods for the treatment of abnormal muscular activity, movement disorders, and related conditions.
    Type: Application
    Filed: August 12, 2021
    Publication date: December 9, 2021
    Inventors: David Stamler, Michael Huang
  • Methods for the Treatment of Abnormal Involuntary Movement Disorders
    Publication number: 20210275517
    Abstract: Disclosed herein are new dosage regimens for deuterium-substituted benzoquinoline compounds, and methods for the treatment of abnormal muscular activity, movement disorders, and related conditions.
    Type: Application
    Filed: March 25, 2021
    Publication date: September 9, 2021
    Inventors: David Stamler, Michael Fangching Huang
  • METHODS FOR THE TREATMENT OF ABNORMAL INVOLUNTARY MOVEMENT DISORDERS
    Publication number: 20210145820
    Abstract: Disclosed herein are new dosage regimens for deuterium-substituted benzoquinoline compounds, and methods for the treatment of abnormal muscular activity, movement disorders, and related conditions.
    Type: Application
    Filed: January 21, 2021
    Publication date: May 20, 2021
    Inventors: David Stamler, Michael Huang
  • Methods for the treatment of abnormal involuntary movement disorders
    Patent number: 10959996
    Abstract: Disclosed herein are new dosage regimens for deuterium-substituted benzoquinoline compounds, and methods for the treatment of abnormal muscular activity, movement disorders, and related conditions.
    Type: Grant
    Filed: July 19, 2018
    Date of Patent: March 30, 2021
    Assignee: AUSPEX PHARMACEUTICALS, INC.
    Inventors: David Stamler, Michael Fangching Huang
  • BENZOQUINOLINE INHIBITORS OF VESICULAR MONOAMINE TRANSPORTER 2
    Publication number: 20200281917
    Abstract: The present invention relates to new benzoquinoline inhibitors of vesicular monoamine transporter 2 (VMAT2), pharmaceutical compositions thereof, and methods of use thereof.
    Type: Application
    Filed: September 26, 2019
    Publication date: September 10, 2020
    Inventor: David Stamler
  • Methods for the Treatment of Abnormal Involuntary Movement Disorders
    Publication number: 20180318281
    Abstract: Disclosed herein are new dosage regimens for deuterium-substituted benzoquinoline compounds, and methods for the treatment of abnormal muscular activity, movement disorders, and related conditions.
    Type: Application
    Filed: July 19, 2018
    Publication date: November 8, 2018
    Inventors: David Stamler, Michael Fangching Huang
  • BENZOQUINOLINE INHIBITORS OF VESICULAR MONOAMINE TRANSPORTER 2
    Publication number: 20180169087
    Abstract: The present invention relates to new benzoquinoline inhibitors of vesicular monoamine transporter 2 (VMAT2), pharmaceutical compositions thereof, and methods of use thereof.
    Type: Application
    Filed: February 19, 2018
    Publication date: June 21, 2018
    Inventor: David Stamler
  • METHODS FOR THE TREATMENT OF ABNORMAL INVOLUNTARY MOVEMENT DISORDERS
    Publication number: 20180064701
    Abstract: Disclosed herein are new dosage regimens for deuterium-substituted benzoquinoline compounds, and methods for the treatment of abnormal muscular activity, movement disorders, and related conditions.
    Type: Application
    Filed: October 2, 2017
    Publication date: March 8, 2018
    Inventors: David Stamler, Michael Fangching Huang
  • METHODS FOR THE TREATMENT OF ABNORMAL INVOLUNTARY MOVEMENT DISORDERS
    Publication number: 20170326131
    Abstract: Disclosed herein are new dosage regimens for deuterium-substituted benzoquinoline compounds, and methods for the treatment of abnormal muscular activity, movement disorders, and related conditions.
    Type: Application
    Filed: August 2, 2017
    Publication date: November 16, 2017
    Inventors: David Stamler, Michael Fangching Huang
  • METHODS FOR THE TREATMENT OF ABNORMAL INVOLUNTARY MOVEMENT DISORDERS
    Publication number: 20170151227
    Abstract: Disclosed herein are new dosage regimens for deuterium-substituted benzoquinoline compounds, and methods for the treatment of abnormal muscular activity, movement disorders, and related conditions.
    Type: Application
    Filed: February 9, 2017
    Publication date: June 1, 2017
    Inventors: David Stamler, Michael Fangching Huang
  • BENZOQUINOLINE INHIBITORS OF VESICULAR MONOAMINE TRANSPORTER 2
    Publication number: 20160346270
    Abstract: The present invention relates to new benzoquinoline inhibitors of vesicular monoamine transporter 2 (VMAT2), pharmaceutical compositions thereof, and methods of use thereof.
    Type: Application
    Filed: January 22, 2015
    Publication date: December 1, 2016
    Inventor: DAVID STAMLER
  • METHODS FOR THE TREATMENT OF ABNORMAL INVOLUNTARY MOVEMENT DISORDERS
    Publication number: 20160287574
    Abstract: Disclosed herein are new dosage regimens for deuterium-substituted benzoquinoline compounds, and methods for the treatment of abnormal muscular activity, movement disorders, and related conditions.
    Type: Application
    Filed: March 7, 2016
    Publication date: October 6, 2016
    Inventors: David Stamler, Michael Fangching Huang